Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01858311 · ClinicalTrials.gov registry record
Nutrition Blood Outcomes Following Tocotrienol N2B
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 300
- Enrollment target
NCT01858311: Completed study, sponsored by Ohio State University.
NCT01858311 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01858311 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
A natural form of vitamin E called tocotrienol (TCT) has blood thinning and cholesterol lowering properties, both of which may benefit stroke survivors. This study is being conducted to determine the blood thinning and cholesterol lowering properties of TCT in stroke or TIA (transient ischemic attack, which is also referred to as a "mini-stroke") survivors that are receiving the standard treatment for prevention of recurrent stroke. Study Hypothesis: Oral TCT decreases the incidence of aspirin and clopidogrel nonresponders, increases the extent of inhibition of platelet aggregation, and decreases LDL without significant side effects in stroke patients.
Primary Outcome
Platelet aggregation activity will be measured using standard clinical laboratory procedures
Interventions
- OTHER Placebo Vehicle
- DIETARY_SUPPLEMENT Tocotrienol Capsules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2013-03 |
| Est. Completion | 2018-12 |
What the finished NCT01858311 record still lists
NCT01858311 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Placebo Vehicle is the first listed.
NCT01858311 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01858311 about?
NCT01858311 is a clinical study titled "Nutrition Blood Outcomes Following Tocotrienol N2B". A natural form of vitamin E called tocotrienol (TCT) has blood thinning and cholesterol lowering properties, both of which may benefit stroke survivors. This study is being conducted to determine the blood thinning and cholesterol lowering properties of TCT in stroke or TIA (transient ischemic attac...
What is the current status of trial NCT01858311?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2013-03. Estimated completion is 2018-12.
What interventions are being tested in trial NCT01858311?
The interventions under investigation include: Placebo Vehicle (OTHER), Tocotrienol Capsules (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01858311?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia